LLY $139.58 1.85 (1.3%)

    LLY Profile

    LLY trades on the NYSE.

    MEMBERSHIP
    S&P 500




    Eli Lilly is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta and Verzenio for cancer; Forteo for osteoporosis; Jardiance, Trulicity, Humalog, and Humulin for diabetes; Taltz and Olumiant for immunology; and Cialis for erectile dysfunction.

    LLY Earnings


    Q3 Earnings for Jul, Aug & Sep

    Wed, Oct 23, 2019

    Since Earnings Report

    LLY +27.1%


    Q4 Earnings for Oct, Nov & Dec

    Thu, Jan 30, 2020

    LLY Dividend

    Dividend Yield

    2.12%

    Dividend Rate

    $2.96


    Ex-Dividend Date

    Thu, Feb 13, 2020


    Dividend Pay Date

    Tue, Mar 10, 2020



    Dividend Payments

    137 Payments


    LLY Industry Competitors


    BIOTECH & PHARMA
    Johnson & Johnson
    Merck
    Pfizer
    Bristol-Myers Squibb
    Novo Nordisk A/S
    Amgen
    AbbVie
    Sanofi SA (ADR)
    Gilead Sciences
    Celgene

    BIOTECH & PHARMA



    Symbol MC DY Price Day YTD
    LLY $135.48 2.12% $139.58 -1.3% 5.6%






        TOP    




    info@symbolsurfing.com


    Stock Market Terms

    Remove Blur With Premium Subscription

    Symbol Surfing

    ©2020 Symbol Surfing All Rights Reserved.

    Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

    Cookies Policy Terms Of Service Privacy Policy